Introduction
============

Tetrachloroethylene (perchloroethylene, or PCE) is a widely used chlorinated solvent that is produced commercially for use in dry cleaning, textile processing, and metal-cleaning operations. PCE has been detected in drinking water, indoor environments, ambient air, groundwater, and soil. Many point sources of contamination exist in the United States \[[@r110]\], and PCE is also commonly found at Superfund hazardous waste sites ([@r109]). Regarding exposure to the general population, the [@r18] reported that PCE levels assessed in the most recent biomonitoring survey \[the 2003--2004 subsample of the National Health and Nutrition Examination Survey (NHANES)\] appeared to be similar or slightly lower than levels reported in earlier NHANES surveys. The primary exposure routes are via inhalation, including as a result of vapor intrusion from contaminated soil and water ([@r111]), and ingestion of contaminated water.

The U.S. EPA identified PCE as a priority existing chemical for regulatory action review under the Toxic Substances Control Act ([@r107]) and as one of several volatile organic compounds to be regulated as a group in drinking water ([@r104]). Supporting these and other agency actions, the U.S. EPA Integrated Risk Information System (IRIS) program released an updated human health assessment of PCE in February 2012 that included an extensive toxicological review ([@r106]), hereafter referred to as the Toxicological Review. The Toxicological Review was developed according to the general guidelines for risk assessment set forth by the National Research Council ([@r68], [@r69]) as well as relevant U.S. EPA Guidelines and Risk Assessment Forum technical panel reports ([@r108]). The literature search strategy was based on the Chemical Abstracts Service Registry Number (CASRN) and at least one common name. Primary peer-reviewed literature published during or before August 2011 was included. Public submissions to the U.S. EPA and peer-reviewed information (including health assessments developed by other organizations, review articles, and independent analyses of the health effects data) were also considered for inclusion. Toxicokinetic, mechanistic, and other data (e.g., tumor latency, severity, background rate) were considered in interpreting experimental animal cancer findings. Individual study evaluation considered essential design features (particularly, the study species and its population and the relevance of the exposure paradigm); other considerations are discussed in the following sections. The Toxicological Review ([@r106]) provides additional detail regarding the source literature databases, the relevant U.S. EPA guidance, and the study evaluation criteria.

The assessment development involved multiple internal and external peer review stages. Critical input was provided by a 2004 peer consultation workshop on PCE neurotoxicity ([@r101]), a 2010 NRC panel report ([@r70]), a 2011 peer review of the physiologically based pharmacokinetic (PBPK) model applications ([@r106]), and written and oral comments from scientists within the U.S. EPA, other federal agencies, and the Office of Management and Budget ([@r105]) as well as the public ([@r82]). Herein we describe key findings and scientific issues addressed in the U.S. EPA's 2012 Toxicological Review of PCE, covering the following topics:

1.  The role of metabolism in toxicity, informed by the development and application of an updated PBPK model

2.  The carcinogenicity of PCE, based on analyses of epidemiological studies, multiple laboratory animal bioassays, and mechanistic data

3.  Noncancer toxicity, focusing on neurotoxicity as a sensitive outcome.

Role of Metabolism in PCE Toxicity
==================================

PBPK models can aid in integrating complex toxicokinetic information on the absorption, distribution, metabolism, and excretion of environmental chemicals and their metabolites. These models are constructed from physiologic information in addition to chemical- and metabolite-specific toxicokinetic data. Some models separate data sets for model calibration and evaluation, utilizing Bayesian methods to strengthen model predictions. PBPK models are used in human health assessments to predict the extent and nature of metabolism across species or exposure routes.

The metabolism of PCE yields multiple metabolites through two main irreversible pathways: *a*) oxidation via the microsomal mixed-function oxidase system \[i.e., cytochrome P450s (CYPs)\], and *b*) conjugation with glutathione (GSH) by glutathione *S*-transferases (GSTs) ([@r53]). Oxidation ([Figure 1](#f1){ref-type="fig"}, left) occurs predominantly in the liver to a ferric-oxide (Fe-O) intermediate, the primary fate of which is thought to be trichloroacetyl chloride (TCAC), which then hydrolyses to yield trichloroacetic acid (TCA). A secondary fate of oxidation is the epoxide (PCE-O), which decomposes to ethandioyl dichloride (EDD) and then to carbon monoxide (CO) and carbon dioxide (CO~2~) ([@r123]). Oxalic acid (OXA) has been reported as both an *in vivo* and *in vitro* product of PCE oxidation ([@r75]; [@r123]) and may be derived either from the epoxide or directly from the Fe-O intermediate. PCE conjugation with GSH ([Figure 1](#f1){ref-type="fig"}, right) in the liver or kidney forms trichlorovinyl glutathione (TCVG), which is further processed by γ-glutamyl transpeptidase (GGT) and cysteinylglycine dipeptidase (DP) in the kidney, forming the cysteine conjugate *S*-trichlorovinyl-[l]{.smallcaps}-cysteine (TCVC). TCVC may be bioactivated by β-lyase or by flavin-containing monooxygenases (FMO3s) or CYP3A to reactive species ([@r2]; [@r51]), or (reversibly) may undergo *N*-acetylation \[by *N*-acetyltransferase (NAT)\] to the mercapturate *N*-acetyl trichlorovinyl cysteine (NAcTCVC). NAcTCVC is then excreted in urine or sulfoxidated by CYP3A to reactive species ([@r122]). Dichloroacetic acid (DCA), excreted in urine, is thought to be an end product of β-lyase--mediated bioactivation ([@r53]), although a small contribution from TCA dechlorination cannot be ruled out.

![Simplified PCE metabolism scheme. PCE is metabolized in humans and experimental animal species by both oxidation (left) and GSH conjugation (right) metabolic pathways, yielding numerous toxicologically active compounds ([@r53]). Tetrachlorethylene metabolism yields the oxidative metabolites TCAC, which hydrolyses to yield TCA, and the epoxide PCE-O, which decomposes in turn to EDD, CO, and CO~2~. OXA is also a product of PCE oxidation. GSH conjugation products include TCVG, the cysteine conjugate TCVC, and the mercapturate NAcTCVC and its sulfoxidation products. DCA is likely produced via β-lyase--mediated bioactivation, although TCA dechlorination may be an additional minor source. \*Metabolites identified in blood, urine, or breath after *in vivo* PCE exposure (rodent or human).](ehp.1307359.g001){#f1}

PCE liver effects are thought to result from oxidative metabolites ([@r13]), whereas metabolites resulting from GSH conjugation are hypothesized to cause kidney effects ([@r53]). The identity of PCE metabolites involved in the induction of other PCE health effects is less clear, although PCE itself has been presumed to cause neurological effects (e.g., [@r11]).

Many PBPK models for PCE have been developed to predict the relationship between external measures of exposure and internal dose \[[@r9] (updated by [@r22]); [@r19]; [@r21]; [@r25]; [@r28] (updated by [@r79]); [@r38]; [@r56]; [@r81]; [@r83]\]. These PBPK models have led to a wide range of predictions for the amount of PCE metabolized in humans at low exposure levels, with estimates across the various models spanning an order of magnitude or more ([@r23]).

In an attempt to reconcile these uncertainties, [@r23] developed a harmonized PBPK model that integrated the previous models and data. The harmonized model predicted oxidative metabolism with fairly high confidence. However, estimates of the extent of GSH conjugation in humans were substantially more uncertain, spanning more than three orders of magnitude. These predictions provide a plausible explanation for the apparently inconsistent findings among previously published models. In particular, previously conducted analyses that concluded low total metabolism (roughly 1% of PCE uptake) also assumed that TCA (derived from oxidative metabolism) represented 30--100% of total metabolism (e.g., [@r20]; [@r25]; [@r28]; [@r79]). These results are consistent with the [@r23] model predictions that oxidative metabolism is low in humans. On the other hand, previous analyses that concluded greater metabolism (\> 20% of PCE uptake) either allowed for both oxidative metabolism and GSH conjugation, or made inferences based on the disappearance of the parent compound \[e.g., [@r10], [@r9]; [@r22]; [@r83]; [@r120]\]. These results are consistent with the [@r23] model predictions that the amount of GSH conjugation metabolism in humans is highly uncertain, and might be high, low, and/or highly variable.

Carcinogenicity
===============

*Evaluation of cancer epidemiology data*. Much of the epidemiological research has been conducted in the dry-cleaning industry, in which PCE was widely used from 1960 onward in the United States and Europe. A recent comprehensive review of 109 occupational studies with exposure measures estimated a mean exposure of 59 ppm in dry-cleaning workers based on personal measurements ([@r41]). These measures varied considerably with the type of work, however, ranging from \< 10 ppm for spotters, pressers, and counter clerks to \> 100 ppm for machine operators. Exposures in metal and plastic degreasing industries were also high (mean of approximately 100 ppm).

A key consideration in the evaluation of these studies was the quality (e.g., the specificity) of the exposure assessment methods. The ability of a study to identify cancer hazards is strengthened by "higher quality or higher specificity" exposure-assessment approaches that allow for a delineation of exposure potential to individual study subjects. In particular, these exposure-assessment methodologies included *a*) biological monitoring data, *b*) cohort studies using a job-exposure matrix based on historical industrial monitoring data, *c*) case--control studies using a job-exposure matrix focusing on PCE based on information on job title and tasks or duties, *d*) additional sources of information such as union records or modules for specific jobs, and *e*) studies of residential PCE exposure using a statistical model of the water distribution system to estimate the delivered dose to a study subject's home ([Table 1](#t1){ref-type="table"}). Because of the variability in exposure potential within dry-cleaning occupations, less specific exposure-assessment approaches (e.g., through broader job title groups or plant- or geographically based classifications) were given less weight but were not excluded from the hazard evaluation. Other study quality considerations included a lack of support for alternative explanations for observed associations (e.g., bias or confounding).

###### 

Results of epidemiological studies of PCE and bladder cancer, non-Hodgkin lymphoma, or multiple myeloma using higher quality exposure assessment methodology.

  Study type/reference, population, design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Exposure surrogate                      Bladder cancer RR (95% CI) \[*n*\]^*a*^   non-Hodgkin lymphoma RR (95% CI) \[*n*\]^*a*^   Multiple myeloma RR (95% CI) \[*n*\]^*a*^
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ----------------------------------------- ----------------------------------------------- -------------------------------------------
  Cohort studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Antilla et al. 1995 (Finland): biologically monitored workers (SIR), blood PCE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Any PCE                                 Not reported                              3.76 (0.77, 11.0) \[3\]                         (Expected = 0.38) \[0\]
  Boice et al. 1999 (United States): aerospace workers (SMR, RR), job-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Any routine exposure to PCE             0.70 (0.09, 2.53) \[2\]                   1.70 (0.73, 3.34) \[8\]                         0.40 (0.01, 2.25) \[1\]
  Duration, among those with routine or intermittent exposure to PCE:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  No routine or intermittent exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Not reported                            1.0 (Referent) \[32\]                     1.0 (Referent) \[24\]                           
  \< 1 year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1.25 (0.43, 3.57) \[4\]                   0.46 (0.06, 3.48) \[1\]                         
  1--4 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1.11 (0.46, 2.70) \[6\]                   1.13 (0.38, 3.35) \[4\]                         
  ≥ 5 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1.41 (0.67, 3.00) \[10\]                  0.24 (0.03, 1.84) \[1\]                         
  Blair et al. 2003 (United States): laundry and dry-cleaning workers (SMR), union records                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Little to no PCE exposure               1.4 (0.4, 3.2) \[5\]                      Not reported                                    Not reported
  Medium-to-high PCE exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1.5 (0.6, 3.1) \[7\]                                                                                                              
  Lynge et al. 2006 (Sweden, Denmark, Finland, Norway): nested case--control, census occupation codes and pension data/questionnaires                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Dry-cleaner job title                   1.44 (1.07, 1.93) \[93\]                  Not studied                                     Not studied
  Employment duration (dry cleaner):                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Not studied                               Not studied                                     
  Never                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1.0 (Referent) \[188\]                                                                                                            
  \< 1 year                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1.50 (0.57, 3.96) \[6\]                                                                                                           
  2--4 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2.39 (1.09, 5.22) \[10\]                                                                                                          
  5--9 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           0.91 (0.52, 1.59) \[17\]                                                                                                          
  \> 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1.57 (1.07, 2.29) \[54\]                                                                                                          
  Unknown duration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1.97 (0.64, 6.05) \[6\]                                                                                                           
  Radican et al. 2008 (United States): aircraft maintenance workers (RR, internal referent), job-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Any PCE:                                                                                                                          
  Males                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Not reported                            2.32 (0.75, 7.15) \[5\]                   1.71 (0.42, 6.91) \[3\]                         
  Females                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not reported                            2.35 (0.52, 10.7) \[2\]                   7.84 (1.43, 43.1) \[2\]                         
  Seldén and Ahlborg 2011 (Sweden): dry-cleaning workers (SIR), census occupation codes, questionnaire, and company-provided data pertaining to solvent use                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Any PCE:                                                                                                                          
  Males                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Not reported                            2.02 (1.13, 3.34) \[15\]                  Not reported                                    
  Females                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not reported                            1.14 (0.68, 1.81) \[18\]                  Not reported                                    
  Calvert et al. 2011 (United States): laundry and dry-cleaning workers (SMR), union employment records (PCE-only exposure based on history of solvent use by shops)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Any PCE                                 Not reported \[0\]                        2.46 (0.90, 5.36) \[6\]                         Not reported
  Case--control studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Aschengrau et al. 1993 \[United States (Massachusetts)\]: residential history, ordinal estimate of PCE-contaminated water from exposure model                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Any PCE                                 1.39 (0.67, 2.91) \[13\]                  Not studied                                     Not studied
  Any PCE \> 90th percentile relative delivered dose                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   4.03 (0.65, 25.10) \[4\]                Not studied                               Not studied                                     
  Pesch et al. 2000 (Germany): job- and task-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Any PCE (males):                                                                  Not studied                                     Not studied
  Medium exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1.0 (0.7, 1.5) \[37\]                                                                                                             
  High exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1.3 (0.8, 1.7) \[47\]                                                                                                             
  Substantial exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1.8 (1.1, 3.1) \[22\]                                                                                                             
  Miligi et al. 2006^*b*^, Costantini et al. 2008^*b*^ (Italy): job-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Any PCE:                                Not studied                                                                               
  Very low/low intensity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       0.6 (0.3, 1.2) \[18\]^*c*^                Not reported \[3\]                              
  Medium/high intensity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1.2 (0.6, 2.5) \[14\]^*c*^                Not reported \[2\]                              
  Seidler et al. 2007 (Germany): job-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PCE, cumulative exposure (ppm-years):   Not studied                                                                               
  0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1.0 (Referent) \[667\]                    1.0 (Referent) \[33\]                           
  \> 0 to ≤ 9.1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1.1 (0.5, 2.3) \[16\]^*d*^                1.8 (0.5, 6.7) \[3\]                            
  \> 9.1 to ≤ 78.8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1.0 (0.5, 2.2) \[14\]^*d*^                \[0\]                                           
  \> 78.8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3.4 (0.7, 17.3) \[6\]^*d*^                \[0\]                                           
  Gold et al. 2010 (United States): all jobs held \>12 months, job-exposure matrix                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Any PCE                                 Not studied                               Not studied                                     1.5 (0.8, 2.9) \[16\]
  Cumulative PCE exposure (ppm-weeks):                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Not studied                             Not studied                                                                               
  0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1.0 \[164\]                                     
  1--353                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 0.3 (0.04, 3.0) \[1\]                           
  354--1,430                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             0.5 (0.1, 4.4) \[1\]                            
  1,431--4,875                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1.5 (0.4, 5.4) \[4\]                            
  4,876--13,500                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3.3 (1.2, 9.5) \[10\]                           
  Abbreviations: RR, relative risk; SIR, standardized incidence ratio; SMR, standardized mortality ratio. ^***a***^*n* refers to the number of exposed cases. ^***b***^Both Miligi et al. (2006) and Costantini et al. (2008) are based on the Italian Multicenter Case--control Study on Hematolymphopoietic Malignancies and Exposure to Solvents and Pesticides. Miligi et al. (2006) reported ORs for non-Hodgkin lymphoma and PCE; Costantini et al. (2008) reported ORs for multiple myeloma and PCE. ^***c***^Includes patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia. ^***d***^Includes patients with non-Hodgkin and Hodgkin lymphoma.                                                                                                                                     

The epidemiological evidence from cohort and case--control studies provides evidence of associations between PCE exposure and bladder cancer, non-Hodgkin lymphoma, and multiple myeloma in adults. Of these, bladder cancer and non-Hodgkin lymphoma were considered to have the strongest databases on the basis of the relative consistency of an observed association among studies with the higher quality exposure measurement and indication of increasing risk with increasing exposure among the studies using a cumulative exposure metric.

[Table 1](#t1){ref-type="table"} summarizes cohort and case--control studies of bladder cancer, non-Hodgkin lymphoma, and multiple myeloma using a higher quality exposure assessment methodology; summaries of the other cancer sites can be found in the Toxicological Review ([@r106]). Studies of dry cleaners, launderers, and pressers used additional information to distinguish PCE-exposed workers from other workers ([@r7]; [@r16]; [@r57]; [@r77]; [@r95]). Specificity was also improved in studies in other work settings and in population-based case--control studies that used an individual-level exposure assignment (e.g., through a job-exposure matrix, PCE in blood as a biological marker, or a statistical model of water distribution to estimate a delivered PCE dose to a study subject's home ([@r3]; [@r4]; [@r8]; [@r42]; [@r64]; [@r80]; [@r94]). Smoking history was considered a potential confounder only in the bladder cancer studies because it is not a known risk factor for non-Hodgkin lymphoma or multiple myeloma.

For bladder cancer, two moderate-sized (\> 20 exposed cases) studies used a relatively specific exposure assessment method ([@r57]; [@r77]). [@r77] observed odds ratios (ORs) of 1.0, 1.2, and 1.8 for the medium, high, and substantial exposure categories, respectively; however, the pattern was more variable in the nested case--control study by [@r57], in which duration of dry-cleaning work was used as the exposure measure. Smoking is a risk factor for bladder cancer, and could also be related to TCE exposure. The case--control studies addressed this potential confounding by adjusting for smoking. The studies of dry-cleaning workers are also useful in that the study subjects are unlikely to have been exposed to other occupational bladder carcinogens. In the small studies (\< 10 exposed cases) of non-Hodgkin lymphoma, an approximate doubling of risk compared with the referent population was seen ([@r3]; [@r8]; [@r16]; [@r80]; [@r95]), and a relative risk of 3.4 (95% CI: 0.7, 17.3) was seen in the highest cumulative exposure group in [@r94]. Multiple myeloma is a relatively rare type of cancer, and results for multiple myeloma are based on a smaller set of studies and fewer observed cases than those for non-Hodgkin lymphoma. The largest of these studies, with 16 exposed cases, reported an OR of 3.3 (95% CI: 1.2, 9.5) for the highest exposure group compared with the unexposed group ([@r42]). For each of the three cancer types above, the epidemiological data were considered to provide evidence suggestive of a causal association. For cancers of other sites, including esophageal, kidney, lung, liver, cervical, and breast cancer, results were more variable (data not shown). Studies of cancer in children exposed prenatally or postnatally to PCE were inadequate to allow for drawing firm conclusions ([@r12]).

*Evaluation of experimental evidence of carcinogenicity*. There is clear evidence of PCE carcinogenicity in rodents: one oral gavage \[[@r66]\] and two inhalation \[[@r49]; [@r72]\] cancer bioassays, all in sexually mature animals. No data were available on cancer risks in experimental animals exposed to PCE during early life stages. As summarized in [Table 2](#t2){ref-type="table"}, a number of factors were considered in evaluating the rodent carcinogenicity findings. These included statistical analyses to adjust for survival differences and cause of death and mode-of-action analyses to inform judgments regarding human relevance of animal bioassay results and susceptible populations or life stages ([@r103]).

###### 

Summary of factors considered in evaluating carcinogenicity findings in experimental animals.

  Tumor type                                                                                  Incidence (dose, sex, strain, route)                                                                                                                                                                                              Tumor latency, severity, mortality, background rate                                                                                                                                                          Toxicokinetic information                                                           MOA information
  ------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rat mononuclear cell leukemia                                                               Significant increases in both sexes of F344/N (NTP 1986) and F344/DuCrj (JISA 1993) strains; dose-dependent increase in F344/DuCrj males (JISA 1993)                                                                              NTP 1986: decreased latency in females; increased severity in both sexes; background rate 56% in males, 36% in females JISA 1993: decreased latency in both sexes; background rate of \~ 20% in both sexes   No information available concerning active moiety(ies)                              None hypothesized; studies demonstrating hemolysis and bone marrow toxicity in mice add some support to the biologic plausibility
  Mouse hepatocellular tumors                                                                 Significant, dose-dependent increases in both sexes of B6C3F~1~ (NTP 1986) and Crj:BDF1 (JISA 1993) strains with inhalation exposures; no continued increase with increasing dose in gavage study of B6C3F~1~ strain (NCI 1977)   Decreased latency; increased mortality; increased metastases in inhalation studies; background rate of \~ 30% in males, \~ 8% in females                                                                     The metabolites TCA and DCA are mouse hepatocarcinogens, alone and in combination   Evidence is insufficient for the hypothesized MOAs evaluated: PPARα activation, mutagenicity, alterations in DNA methylation, oxidative stress secondary to cytotoxicity
  Mouse hemangiomas, hemangiosarcomas                                                         Significant, dose-dependent increases in males in one bioassay (Crj:BDF1 strain, JISA 1993)                                                                                                                                       Background rate of 2--4% in both sexes; decreased latency                                                                                                                                                    No information available concerning active moiety(ies)                              None hypothesized
  Rat kidney tumors                                                                           Significant trend in males in one bioassay (F344/N strain, NTP 1986)                                                                                                                                                              Low background rate (1/549 among historical controls for facility; \~ 0.2% in 1,968 untreated controls in the NTP program)                                                                                   GSH conjugation metabolites are likely contributors to renal carcinogenicity        Evidence is insufficient for the hypothesized MOA evaluated: α2u-globulin nephropathy did not meet the U.S. EPA criteria for establishing this MOA; evidence of either *a*) cytotoxicity not associated with α2u-globulin accumulation, or *b*) peroxisome proliferation lacked specificity with regard to dose, sex and/or species; limited evidence of mutagenicity (positive Ames assays with GSH conjugation metabolites)
  Abbreviations: MOA, mode of action; PPARα, peroxisome proliferator-­activated receptor α.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

Evaluation of rat tumors. The primary tumor finding in rats was a significant increase in the incidence of mononuclear cell leukemia in both sexes in independent inhalation bioassays using the F344/N ([@r49]; [@r72]) or F344/DuCrj ([@r49]) strain ([Figure 2](#f2){ref-type="fig"}). The [@r72] analyses of the PCE bioassay results revealed an increase in tumor incidence and severity in both sexes and a shortened time to death with mononuclear cell leukemia in female rats. These results were affirmed by statistical analyses performed recently by [@r98] who noted PCE to be 1 of only 5 of the 500 chemicals examined to produce "definitive" leukemia effects in both sexes of rats in NTP bioassays. [@r49] corroborated these results. There is a paucity of data in F344 rats on toxicokinetics or contributing metabolites or mechanisms to inform mode-of-action conclusions. Nonetheless, increases in hemolysis and bone marrow toxicity in NMRI mice after PCE exposure ([@r34]; [@r58]; [@r59], [@r60], [@r61]; [@r93])\] add some support to the biologic plausibility of the observed leukemic effects ([@r70]).

![Dose--response relationships for rat mononuclear cell leukemias (*A*) and mouse hepatocellular tumors (*B*) in PCE bioassays. Three laboratories evaluated PCE in both mice and rats \[oral gavage ([@r66]); inhalation ([@r49]; [@r72])\]. The PBPK model of [@r23] was used to estimate internal dose for each site, allowing comparison of responses across routes of exposure. The best supported dose metric for mouse liver tumors was total oxidative metabolism in the liver (*B*), whereas that for rat mononuclear cell leukemia was PCE area under the curve (PCE AUC) in blood (*A*). The study in Osborne-Mendel rats ([@r66]) was judged inconclusive because of high rates of respiratory disease and mortality with PCE and, thus, rat data from that study are not presented. Survival-adjusted responses are presented as proportion responding (incidence/number at risk).](ehp.1307359.g002){#f2}

Kidney tumors, rare in male rats, were increased in a single bioassay ([@r72]) (see Supplemental Material, Table S1). For rat kidney carcinogenesis, mechanistic data informative for the evaluation of PCE's carcinogenic mode of action were identified (summarized in [Table 2](#t2){ref-type="table"}). PCE metabolites from the GSH conjugation pathway are thought to mediate mechanistic events (other than α2u-globulin nephropathy), contributing to renal carcinogenesis ([@r53]). The GSH conjugation metabolites---TCVG, the cysteine conjugate TCVC, and the mercapturate NAcTCVC---are mutagenic in *Salmonella* tests, consistent with the observation that PCE tested positive for mutagenicity in the few studies in which products of the GSH conjugation metabolic pathway would have been generated ([@r32]; [@r33]; [@r112], [@r113], [@r114]). However, *in vivo* evidence of genotoxicity in the kidney is limited to reports of modest effects after intraperitoneal exposure ([@r63]; [@r118]). Evidence for α2u-globulin nephropathy did not meet the U.S. EPA's criteria for establishing that renal tumors resulted from this mode of action ([@r100]). In addition, evidence of either cytotoxicity not associated with α2u-globulin accumulation, or of peroxisome proliferation, lacked specificity with regard to dose, sex, and/or species.

Another rare rat tumor, brain glioma, was also increased in both sexes in a single bioassay ([@r72]) (see Supplemental Material, Table S1). This study also reported increases in the rate of testicular interstitial cell tumors, a tumor type of high incidence in unexposed male F344 rats. Mechanistic or other data to inform the interpretation of the increases observed in rat brain and testicular tumors in the NTP bioassay were not identified.

Evaluation of mouse tumors. All three bioassays reported an increase in liver tumors in mice exposed to PCE ([@r49]; [@r66]; [@r72]) ([Figure 2](#f2){ref-type="fig"}). Statistical analyses of the gavage study ([@r66]) revealed that the incidence of hepatocellular carcinomas or adenomas was significantly increased and that tumor latency was significantly decreased. A significant association between increased mortality and PCE dose was seen, with liver tumors found in many mice that died before scheduled termination. Inhalation exposure to PCE induced significant, dose-related increases in the incidence of hepatocellular adenomas or carcinomas in both sexes of B6C3F~1~ ([@r72]) and Crj:BDF1 ([@r49]) mice. The incidence of hepatocellular carcinomas that metastasized to the lungs was also significantly increased in the inhalation studies.

The mouse liver tumor evaluation also considered data on the hepatocarcinogenicity of the PCE metabolites TCA and DCA. The primary urinary oxidative metabolite in rodents and humans, TCA, significantly increased the incidence of liver tumors in male and female B6C3F~1~ mice exposed via drinking water for 52--104 weeks ([@r15], [@r14]; [@r30]; [@r46]; [@r76]). Liver tumor incidence increased with increasing concentrations of TCA in drinking water ([@r15], [@r14]; [@r30]; [@r76]). Tumors in TCA-exposed animals developed rapidly, and significant increases were evident in less-than-lifetime studies of ≤ 82 weeks. In addition, TCA was hepatocarcinogenic in mice when coadministered in the drinking water for 52 weeks with the PCE metabolite DCA ([@r14]). DCA alone also causes liver cancer in mice ([@r15]; [@r29]; [@r31]; [@r46]).

The issue of whether TCA can solely account for the hepatocarcinogenicity of PCE was addressed using toxicokinetic analyses because the hepatocarcinogenic potencies of TCA and PCE have not been directly compared in a single rodent bioassay. The U.S. EPA's analysis found that a wide range of possible contributions of TCA to PCE carcinogenicity, from as little as 12% to as much as 100%, is consistent with the available data ([@r106]). A more precise quantitative estimate of the relative contribution of TCA to PCE-induced liver tumors requires an appropriately designed study to better control for experimental variability in kinetics (e.g., dosing patterns in drinking water, metabolism, bioavailability) and dynamics (e.g., background tumor rates).

For hepatocarcinogenesis, a key issue was whether evidence for peroxisome proliferation is sufficient to establish the peroxisome proliferator-activated receptor α (PPARα)--activation mode of action. The relevance to humans of tumors induced by this mode of action has been debated (e.g., [@r26]; [@r45]; [@r50]; [@r86]; [@r87]). For instance, a dissenting opinion provided in the NRC peer review ([@r70], Appendix B) stated that

> the weight of evidence strongly favors a key role of PPARα activation in tetrachloroethylene-induced hepatocarcinogenesis in mice; furthermore, this mode of action lacks relevance for human hepatocarcinogenesis.

However, the NRC peer-review committee as a whole did not support these conclusions, stating in rebuttal that many gaps in knowledge remain with regard to the hepatocarcinogenic mechanisms of PCE. PCE-specific experiments have provided evidence that peroxisomal markers are increased, but at dose levels (i.e., 1,000 mg/kg/day) exceeding those causing liver toxicity, proliferation, or carcinogenicity ([@r73]; [@r78]). In particular, [@r78] reported that CYP4A, a marker of PPARα-activation, was only increased in Swiss Webster mice at the highest PCE dose (1,000 mg/kg/day) and at the earliest (7 days), but not later, time points. In contrast, the study reported a robust dose-dependent proliferative response that persisted for 14--30 days postexposure at 150-, 500-, and 1,000-mg/kg/day levels of PCE. Liver toxicity and repair has been reported at lower doses in other studies in the B6C3F~1~ strain \[e.g., at 100 mg/kg/day ([@r91])\]. Moderate increases in peroxisome proliferation have been reported in rats ([@r73]), a species insensitive to PCE hepatocarcinogenicity. In total, these findings indicate that the modest peroxisome proliferative response to PCE may lack specificity with respect to species, tissue, and dose. The temporal sequence of events also remains to be established. Given these limitations, the database of PCE-specific studies was judged insufficient to demonstrate a causative role of this effect in hepatocarcinogenesis by PCE ([@r106]). PCE and/or its metabolites have been shown to induce a number of other mechanistic events that may also contribute to carcinogenicity, including mutagenicity, alterations in DNA methylation, and oxidative stress ([@r106]).

In addition to mouse liver tumors, hemangiosarcomas or hemangiomas of the liver, spleen, fat, and subcutaneous skin were reported in male mice in one inhalation study ([@r49]) (see Supplemental Material, Table S2). This mouse tumor type was not reported in the NCI oral gavage bioassay ([@r66]), and no increase was reported in the NTP inhalation bioassay ([@r72]). Mechanistic or other data to inform the interpretation of this tumor type were not identified.

*Conclusions on carcinogenic hazard*. Supported by the analyses described above, and following the U.S. EPA's *Guidelines for Carcinogen Risk Assessment* ([@r102]), PCE is characterized as "likely to be carcinogenic to humans" ([@r106]). This characterization is based on suggestive evidence of carcinogenicity in epidemiological studies and conclusive evidence that the administration of PCE, either by ingestion or by inhalation to sexually mature rats and mice, increases tumor incidence ([@r49]; [@r66]; [@r72]). The specific carcinogenic active moiety(ies) and mode(s) of action are not fully characterized, and the hypothesis that mutagenicity contributes to the PCE carcinogenesis has not been ruled out, particularly for kidney carcinogenicity. No data were available on cancer risks in animals exposed to PCE during early life stages.

Noncancer Toxicity
==================

The U.S. EPA's analysis identified the central nervous system, kidney, liver, immune and hematologic systems, and development and reproduction, as target organs of PCE toxicity ([@r107]). Although sufficient for hazard identification, the supporting evidence for several end points was limited for characterizing the relationship of effect with dose at low exposures. Neurotoxicity was supported by a considerable database of human, animal, and mechanistic studies. In addition, neurological effects were generally observed at lower PCE concentrations compared with other noncancer health effects. Further, both the 2004 peer consultation workshop ([@r101]) and the 2010 NRC peer review ([@r70]) affirmed the conclusion that neurotoxicity is a sensitive end point because these effects were observed at lower concentrations and had substantial evidential support. The human and animal neurotoxicity findings supporting the U.S. EPA's conclusions concerning PCE neurotoxicity are summarized below.

*Neurotoxicity*. Human studies regarding neurotoxicological hazard. The three primary neurological domains most consistently associated with subchronic or chronic PCE exposure in human studies were vision, visuospatial memory, and neuropsychological function (e.g., reaction time). Occupational and residential exposure studies support an association of visual deficits after chronic PCE exposure. Deficits in color vision, relative to unexposed study participants, were observed in an occupational study ([@r17]) and in a residential study ([@r90]). In a longitudinal follow-up study to [@r17], [@r40] reported that there was a worsening in the color vision in workers (self-comparison) who were exposed to higher levels of PCE. In the dry-cleaning facilities, color vision deficits, reported as a color confusion index (CCI) ([@r47]), were significantly greater in exposed workers than in unexposed controls, with mean CCI scores of 1.143 and 1.108, respectively (*p* = 0.03) ([@r17]). An additional 6% (*p* \< 0.01) deterioration in mean CCI score relative to their previous score (reported by [@r17]) was seen in workers exposed to increasing concentrations of PCE (median, 1.67--4.35 ppm) 2 years later in a follow-up study of the same worker population ([@r40]). [@r90] reported lower CCI scores, in comparison with a nonexposed residential group, for adult and child residents living within a close proximity to dry cleaners, with mean CCI scores of 1.33 in exposed study participants and 1.20 in controls (*p* = 0.26). In the same study, no difference in CCI scores was observed in day-care workers working in a day-care center next to a dry cleaner in comparison with day-care workers in buildings with no PCE exposure. Two studies did not observe changes in color vision with PCE exposure, but they were limited by having no exposure characterization (Sharanjeet-Kaur et al. 2004) or by using less sensitive color vision testing ([@r65]). In addition, deficits in visual contrast sensitivity relative to unexposed study participants were reported in the two residential populations living or working in buildings co-located with dry cleaners ([@r90]; [@r97]). There was a decreasing trend (*p* \< 0.05) for visual contrast sensitivity in the residential population achieving the maximum contrast sensitivity score at 6 cycles per degree, with 28.3% in the referent group versus 8.3% in the highest exposed (\> 100 μg/m^3^) group ([@r97]).

Associations between exposure and visuospatial memory were also reported in each of the studies that examined this measure in humans. These associations (increased response times or cognition errors) were reported in occupational ([@r35], [@r36]; [@r92]) and residential ([@r1]) studies related to dry-cleaning PCE exposure. In the occupational studies ([@r35], [@r36]; [@r92]), cognition errors ranged from 4 to 30% at exposures of 12--23 ppm, depending on the subtest that was used. In the residential study ([@r1]), visual memory and cognitive function scores were 15% lower in individuals with a mean exposure of 0.7 ppm PCE compared with unexposed individuals. No studies specifically examined visuospatial memory in children.

For neuropsychological function, two studies reported 10--20% increases in simple reaction time, in comparison with an unexposed group, in PCE-exposed occupational ([@r37]) and residential ([@r1]) settings. However, another occupational study reported a 16% improvement in simple reaction time in comparison with unexposed individuals ([@r54]).

Animal studies of neurotoxicological effects. Animal studies of subchronic PCE exposure also observed changes in visual function, cognitive function, and reaction time. In rats, acute inhalation exposure to PCE resulted in changes in visual-evoked potentials ([@r11]; [@r62]). In one subchronic exposure study ([@r62]), a significant increase in amplitude and latency was observed in one peak of the visual-evoked potential responses from a flash stimulus at 5,424 mg/m^3^, but histopathological lesions were not observed in the examination of central and peripheral brain structures (e.g., visual cortex, optic nerve) of the visual system.

Significant decrements in the motor activity domain as measured by increased reaction time, increased number of false alarms, and decreased trial completions in a signal detection task (measures of decreased attention) were reported at ≥ 6,782 mg/m^3^ in an acute exposure study in rats ([@r74]). In addition, deficits in operant tasks that test cognitive performance were seen in rats and mice after acute oral ([@r121]) and intraperitoneal ([@r99]) exposures to PCE. These findings support evidence of deficits in cognition and memory associated with PCE exposure in humans. However, no animal studies to date have evaluated the persistence of cognitive performance deficits from acute or chronic PCE exposure.

Observed changes in brain weight and levels of DNA, RNA, and neurotransmitters in experimental animals are consistent with evidence of neurobehavioral effects of PCE exposure in humans. Brain DNA, RNA and protein levels, as well as lipid composition, were altered after PCE inhalation. Changes were observed in the cerebellum, the hippocampus, and the frontal cortex in sexually mature animals ([@r84]; [@r88], [@r89]; [@r119]) as well as after gestational exposure ([@r52]; [@r67]).

*Conclusions regarding noncancer hazard*. The U.S. EPA's analysis identified the central nervous system, kidney, liver, immune and hematologic systems, and development and reproduction, as target organs of PCE toxicity ([@r107]). Neurotoxicity was identified as among the most sensitive outcomes, occurring at low exposures. The assessment of the neurotoxicity studies drew conclusions through an examination of affected domains (e.g., cognition, vision, motor activity). Human and experimental animal studies provided complementary evidence regarding the association of neurobehavioral deficits and PCE exposure. Studies of humans exposed by inhalation suggest that chronic PCE exposure can result in decrements in vision, visuospatial memory, and, possibly, other aspects of cognition and neuropsychological function, including reaction time. Animal studies provide substantial support for associations of PCE exposure with effects in these domains of neurotoxicity.

Summary
=======

PCE is a widespread contaminant that is present in ambient air, indoor air, soil, drinking water, and groundwater. Once exposed, humans and laboratory animal species rapidly absorb PCE. PCE is then distributed to tissues via the systemic circulation, metabolized, and excreted primarily in breath as unchanged PCE or CO~2~, or in urine as metabolites. The role of metabolism in the toxicity of PCE was informed by the development and application of an updated PBPK model ([@r23]). Low oxidative metabolism was predicted in humans, whereas GSH conjugation metabolism is more uncertain and may be high, low, and/or highly variable. These PBPK model predictions informed the extent and nature of metabolism in different target tissues, and the extrapolation across species and routes of exposure.

Following the U.S. EPA's *Guidelines for Carcinogen Risk Assessment* ([@r102]), PCE was characterized as "likely to be carcinogenic to humans" by all routes of exposure. This characterization is based on suggestive evidence of carcinogenicity in epidemiological studies and conclusive evidence that the administration of PCE, either by ingestion or by inhalation to sexually mature rats and mice, increases tumor incidence ([@r49]; [@r66]; [@r72]).

Neurotoxicity is identified as a sensitive outcome that follows either oral or inhalation exposure to PCE in humans and experimental animals. Associations between exposure and neurotoxic outcomes have been reported by human controlled exposure, occupational, and residential studies as well as experimental animal studies, providing evidence that PCE exposure results in visual changes, increased reaction time, and decrements in cognition.

The U.S. EPA's analysis, approaches, and conclusions are consistent with multiple sets of peer-reviewer recommendations ([@r105]). In addition, the use of evidence tables, narrative syntheses, and other aspects of the assessment approach were in accord with later NRC recommendations for improving IRIS assessments ([@r71]). The International Agency for Research on Cancer recently classified PCE as probably carcinogenic to humans (Group 2A) on the basis of sufficient evidence in animals and limited evidence in humans, consistent with the U.S. EPA's conclusion ([@r44]). Finally, studies of the health effects of PCE published since the U.S. EPA's assessment continue to report associations with neurological outcomes, including studies of illicit drug use ([@r5]); mental illness ([@r6]); visual effects ([@r39]); visuospatial functioning, learning and memory, motor, attention, and mood ([@r48]); and Parkinson disease ([@r43]). Similarly, recent analyses of PCE exposure and cancer continue to add support for human tumor sites identified in the Toxicological Review ([@r24]; [@r55]; [@r85]; [@r115]; [@r116]; [@r117]).

Supplemental Material
=====================

###### 

Click here for additional data file.
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